EKR Therapeutics Wins Approval for Cardene Intravenous Bags
Posted on: Tuesday, 5 August 2008, 09:01 CDT
EKR Therapeutics has received approval from the FDA for Cardene I.V. premixed injection, a patented, ready-to-use, single use intravenous bag for the administration of this calcium channel blocker.
The Cardene I.V. 200ml ready-to-use (RTU) bags contain 20mg of the anti-hypertensive agent nicardipine hydrochloride (0.1mg/ml) in either dextrose or sodium chloride.
EKR further noted that it will start taking orders immediately for the new RTU bags of Cardene. The RTU formulations are expected to expand the Cardene franchise which has primarily consisted of sales of ampoules of Cardene I.V.
Howard Weisman, chairman and CEO of EKR Therapeutics, said: "With the addition of the ready-to-use bags, the breadth of our Cardene product offerings has expanded greatly and we foresee opportunities for wider utilization of this anti-hypertensive across a range of acute-care settings."
Source: Datamonitor
Related Articles
- Stowaway Rattles Traveler With Bite He Won't Forget
- Tea Riding Wave of Coffee Craze
- Bag Yourself a Nugget of Our Mining History
- Pathmark Unveils Online Ordering in Edgewater
- Giant Offers Taste of Future at Camp Hill Supermarket
- Scotts Promotes Targeted Ranges
- The Most Sensuous Experience of My Life
- NE Vive Pas L'Indifference
- Harry Potter Rushes to Beat China Pirates
 |
 |
User Comments (0)
RSS Feeds